The pharmaceutical company on Friday announced that it has appointed Srinivas Sadu as executive chairman and chief executive officer (CEO) of the company, with effect from 10 June 2024.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.